Here are three points:
1. Prior to this appointment, Dr. Hill was CEO and president of Targacept. He also worked for Solvay Pharmaceuticals as president and for ArQule as president and CEO.
2. On the board of directors for Catalyst Biosciences, Dr. Hill is also a board member of Cellectar Biosciences and Lipocine.
3. Dr. Hill received his medical degree from the University of Oxford, United Kingdom.
More articles on orthopedics:
Dr. Mukund Komanduri opens new MK Orthopaedics location: 3 notes
Orthopedic surgeon to know: Dr. Matthew Simons of Sierra Pacific Orthopedics
Dedicated surgeon Dr. Jerome Barton retires — 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
